GlassScriptPhysician profile
William P Jarrett
NPI 1568896470
$59,491.21
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59K · 2022: $14.57 · 2024: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $26,640.17 | 2021 | |
| Abbvie INC. | $17,145.49 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $9,637.91 | 2021 | |
| Upsher-Smith Laboratories LLC | $2,108.08 | 2021 | |
| Allergan, INC. | $1,289.71 | 2021 | |
| Lundbeck LLC | $542.33 | 2021 | |
| Eli Lilly and Company | $500.00 | 2021 | |
| Amgen INC. | $265.97 | 2021 | |
| Emd Serono, INC. | $251.56 | 2021 | |
| Sk Life Science, INC. | $210.57 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $208.00 | 2021 | |
| Eisai INC. | $158.20 | 2021-2024 | |
| Biogen, INC. | $154.27 | 2021 | |
| Sunovion Pharmaceuticals INC. | $129.53 | 2021 | |
| Novartis Pharmaceuticals Corporation | $71.66 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $48.76 | 2021 | |
| Almatica Pharma LLC | $37.38 | 2021 | |
| Mdd US Operations, LLC | $25.01 | 2021 | |
| Greenwich Biosciences, INC. | $19.43 | 2021 | |
| Amneal Pharmaceuticals LLC | $18.50 | 2021 | |
| Abbott Laboratories | $14.57 | 2022 | |
| Livanova USA, INC. | $14.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Jarrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.